✦ LIBER ✦

The role of chemoendocrine agents in postoperative adjuvant therapy for breast cancer: Meta-analysis of the first collaborative studies of postoperative adjuvant chemoendocrine therapy for breast cancer (ACETBC)

✍ Scribed by Osahiko Abe

Book ID: 112956364
Publisher: Springer Japan
Year: 1994
Tongue: English
Weight: 605 KB
Volume: 1
Category: Article
ISSN: 1340-6868
DOI: 10.1007/bf02967368

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Meta-analysis of the second collaborativ

Meta-analysis of the second collaborative study of adjuvant chemoendocrine therapy for breast cancer (acetbc) in patients with stage ii, estrogen-receptor-positive breast cancer

✍ Minoru Yoshida; Osahiko Abe; Junichi Uchino; Kaneo Kikuchi; Rikiya Abe; Kohji En 📂 Article 📅 1997 🏛 Springer Japan 🌐 English ⚖ 734 KB

Postoperative adjuvant randomised trial

Postoperative adjuvant randomised trial comparing chemoendocrine therapy, chemotherapy and immunotherapy for patients with stage II breast cancer: 5-year results from the nishinihon cooperative study group of adjuvant chemoendocrine therapy for breast cancer (ACETBC) of Japan

✍ T. Morimoto; M. Ogawa; K. Orita; K. Sugimachi; T. Toge; K. Dohi; Y. Nomura; Y. M 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 899 KB

The evolving role of postoperative adjuv

The evolving role of postoperative adjuvant radiation therapy for pancreatic cancer

✍ Garofalo, Michael C.; Kwok, Young; Regine, William F. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 320 KB

The role of bisphosphonates as adjuvant

The role of bisphosphonates as adjuvant therapy for breast cancer

✍ Julie R. Gralow 📂 Article 📅 2001 🏛 Current Science Inc. 🌐 English ⚖ 405 KB

The role of adjuvant monoclonal antibody

The role of adjuvant monoclonal antibody therapy for breast cancer: Rationale and new studies

✍ Edith A. Perez 📂 Article 📅 2001 🏛 Current Science Inc. 🌐 English ⚖ 218 KB

Randomized adjuvant trial to evaluate th

Randomized adjuvant trial to evaluate the addition of tamoxifen and PSK to chemotherapy in patients with primary breast cancer: 5-year results from the nishi-nippon group of the adjuvant chemoendocrine therapy for breast cancer organization

✍ Masakazu Toil; Takao Hattori; Masanobu Akagi; Kiyoshi Lnokuchi; Kunzo Orita; Kei 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 714 KB

Background. A randomized adjuvant trial was conducted from October 1982 to January 1985 to evaluate the addition of tamoxifen (TAM) to combination chemotherapy with perioperative mitomycin C (MMC) and ftorafur (FT) for patients with estrogen receptor (ER)-positive tumors and the addition of PSK, a b